16 October 2012, London, Manchester, Munich, Boston, Sydney, Melbourne: Underlining its 20 percent plus growth in revenues during 2012, and its international expansion, College Hill Life Sciences is pleased to have attracted a prestigious roster of new companies to its client base. New clients range from start-ups to multi-nationals, both for fully retained services and for branding and PR projects.
Within Europe, new clients include Biofortuna, Clinigen, C5 Labs, Mission Therapeutics, Pi2 Solutions and BioGasol. New US-based clients include Aptalis Pharmaceutical Technologies and Inspiration Bio, with Australian-based clients being MiReven, Genea Stem Cells and Vaxxas. Prima BioMed is a new client that is listed in all three geographies, reflecting the very international basis of the life sciences industry and College Hill’s ability to offer a globally integrated service.
“We love the life sciences space – it’s great to be able to work with bright and ambitious entrepreneurs and their investors to help new companies take their first steps; and equally rewarding to work with brand-leading established multinationals to support their continued success”, said Sue Charles, Managing Partner, College Hill Life Sciences.
“Our mix of services and highly experienced team has enabled us to continue to grow ourselves, and we are always delighted to welcome new clients to the fold” she added.
For further information:
Sue Charles, Managing Partner
UK: +44 (0)20 7457 2020/ +44 (0)7968 726 585
Australia: +61 (0)457 924 218
USA: +1 347 448 3210